In silico prediction of the lipid-lowering efficacy of the oral PCSK9 inhibitor enlicitide using a mechanistic computational model

Atherosclerosis 2026 Open access

Read full text

Authors: Bertrand Cariou, Yishu Wang, Denis Angoulvant, Franck Boccara, Guillaume Mahé, Philippe Gabriel Steg, Emmanuelle Bechet

DOI: 10.1016/j.atherosclerosis.2026.120682

Cited by: 1

References: 8

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cancer Lipids and Metabolism Pharmaceutical Practices and Patient Outcomes

References 8